Structure-Based Drug Design of Potent Pyrazole Derivatives against Rhinovirus Replication

Laurène Da Costa, Els Scheers, Antonio Coluccia, Adriano Casulli, Manon Roche, Carole Di Giorgio, Johan Neyts, Thierry Terme, Roberto Cirilli, Giuseppe La Regina, Romano Silvestri, Carmen Mirabelli, Patrice Vanelle

Research output: Contribution to journalArticle

Abstract

Rhinoviruses (RVs) have been linked to exacerbations of many pulmonary diseases, thus increasing morbidity and/or mortality in subjects at risk. Unfortunately, the wide variety of RV genotypes constitutes a major hindrance for the development of Rhinovirus replication inhibitors. In the current investigation, we have developed a novel series of pyrazole derivatives that potently inhibit the Rhinovirus replication. Compounds 10e and 10h behave as early stage inhibitors of Rhinovirus infection with a broad-spectrum activity against RV-A and RV-B species (EC50 < 0.1 μM). We also evaluate the dynamics of the emerging resistance of these promising compounds and their in vitro genotoxicity. Molecular docking experiments shed light on the pharmacophoric elements interacting with residues of the drug-binding pocket.

Original languageEnglish
Pages (from-to)8402-8416
Number of pages15
JournalJournal of Medicinal Chemistry
Volume61
Issue number18
DOIs
Publication statusPublished - Sep 27 2018

Fingerprint

Rhinovirus
Drug Design
Drug Residues
pyrazole
Lung Diseases
Genotype
Morbidity
Mortality
Infection

Cite this

Structure-Based Drug Design of Potent Pyrazole Derivatives against Rhinovirus Replication. / Da Costa, Laurène; Scheers, Els; Coluccia, Antonio; Casulli, Adriano; Roche, Manon; Di Giorgio, Carole; Neyts, Johan; Terme, Thierry; Cirilli, Roberto; La Regina, Giuseppe; Silvestri, Romano; Mirabelli, Carmen; Vanelle, Patrice.

In: Journal of Medicinal Chemistry, Vol. 61, No. 18, 27.09.2018, p. 8402-8416.

Research output: Contribution to journalArticle

Da Costa, L, Scheers, E, Coluccia, A, Casulli, A, Roche, M, Di Giorgio, C, Neyts, J, Terme, T, Cirilli, R, La Regina, G, Silvestri, R, Mirabelli, C & Vanelle, P 2018, 'Structure-Based Drug Design of Potent Pyrazole Derivatives against Rhinovirus Replication', Journal of Medicinal Chemistry, vol. 61, no. 18, pp. 8402-8416. https://doi.org/10.1021/acs.jmedchem.8b00931
Da Costa, Laurène ; Scheers, Els ; Coluccia, Antonio ; Casulli, Adriano ; Roche, Manon ; Di Giorgio, Carole ; Neyts, Johan ; Terme, Thierry ; Cirilli, Roberto ; La Regina, Giuseppe ; Silvestri, Romano ; Mirabelli, Carmen ; Vanelle, Patrice. / Structure-Based Drug Design of Potent Pyrazole Derivatives against Rhinovirus Replication. In: Journal of Medicinal Chemistry. 2018 ; Vol. 61, No. 18. pp. 8402-8416.
@article{1f458297ebdc40359d7323a239b96145,
title = "Structure-Based Drug Design of Potent Pyrazole Derivatives against Rhinovirus Replication",
abstract = "Rhinoviruses (RVs) have been linked to exacerbations of many pulmonary diseases, thus increasing morbidity and/or mortality in subjects at risk. Unfortunately, the wide variety of RV genotypes constitutes a major hindrance for the development of Rhinovirus replication inhibitors. In the current investigation, we have developed a novel series of pyrazole derivatives that potently inhibit the Rhinovirus replication. Compounds 10e and 10h behave as early stage inhibitors of Rhinovirus infection with a broad-spectrum activity against RV-A and RV-B species (EC50 < 0.1 μM). We also evaluate the dynamics of the emerging resistance of these promising compounds and their in vitro genotoxicity. Molecular docking experiments shed light on the pharmacophoric elements interacting with residues of the drug-binding pocket.",
author = "{Da Costa}, Laur{\`e}ne and Els Scheers and Antonio Coluccia and Adriano Casulli and Manon Roche and {Di Giorgio}, Carole and Johan Neyts and Thierry Terme and Roberto Cirilli and {La Regina}, Giuseppe and Romano Silvestri and Carmen Mirabelli and Patrice Vanelle",
year = "2018",
month = "9",
day = "27",
doi = "10.1021/acs.jmedchem.8b00931",
language = "English",
volume = "61",
pages = "8402--8416",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "18",

}

TY - JOUR

T1 - Structure-Based Drug Design of Potent Pyrazole Derivatives against Rhinovirus Replication

AU - Da Costa, Laurène

AU - Scheers, Els

AU - Coluccia, Antonio

AU - Casulli, Adriano

AU - Roche, Manon

AU - Di Giorgio, Carole

AU - Neyts, Johan

AU - Terme, Thierry

AU - Cirilli, Roberto

AU - La Regina, Giuseppe

AU - Silvestri, Romano

AU - Mirabelli, Carmen

AU - Vanelle, Patrice

PY - 2018/9/27

Y1 - 2018/9/27

N2 - Rhinoviruses (RVs) have been linked to exacerbations of many pulmonary diseases, thus increasing morbidity and/or mortality in subjects at risk. Unfortunately, the wide variety of RV genotypes constitutes a major hindrance for the development of Rhinovirus replication inhibitors. In the current investigation, we have developed a novel series of pyrazole derivatives that potently inhibit the Rhinovirus replication. Compounds 10e and 10h behave as early stage inhibitors of Rhinovirus infection with a broad-spectrum activity against RV-A and RV-B species (EC50 < 0.1 μM). We also evaluate the dynamics of the emerging resistance of these promising compounds and their in vitro genotoxicity. Molecular docking experiments shed light on the pharmacophoric elements interacting with residues of the drug-binding pocket.

AB - Rhinoviruses (RVs) have been linked to exacerbations of many pulmonary diseases, thus increasing morbidity and/or mortality in subjects at risk. Unfortunately, the wide variety of RV genotypes constitutes a major hindrance for the development of Rhinovirus replication inhibitors. In the current investigation, we have developed a novel series of pyrazole derivatives that potently inhibit the Rhinovirus replication. Compounds 10e and 10h behave as early stage inhibitors of Rhinovirus infection with a broad-spectrum activity against RV-A and RV-B species (EC50 < 0.1 μM). We also evaluate the dynamics of the emerging resistance of these promising compounds and their in vitro genotoxicity. Molecular docking experiments shed light on the pharmacophoric elements interacting with residues of the drug-binding pocket.

U2 - 10.1021/acs.jmedchem.8b00931

DO - 10.1021/acs.jmedchem.8b00931

M3 - Article

VL - 61

SP - 8402

EP - 8416

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 18

ER -